In much accordance to our results, a recent study has documented that metformin can augment the anti-proliferative effect of sorafenib on HCC cells HepG2 and Huh-7 through ferroptosis induction by blocking the p62-Keap1-Nrf2/HO1 signaling pathway (11). Here, HMOX1 is linked to hepatocellular carcinoma.